Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Pregnancy in patients with ankylosing spondylitis: Do regulatory T cells play a role?
Arthritis Care and Research , 02/03/09
Förger F et al. - Study documents that pregnancy influenced the expansion and cytokine secretion of regulatory T (Treg) cells in both patients with ankylosing spondylitis (AS) and control subjects. However, the Treg cells of pregnant pts with AS failed to support an antiinflammatory cytokine milieu, thereby possibly contributing to the persistent disease activity during pregnancy.
Methods- Aim was to investigate the numerical and functional changes of CD4+CD25high Treg cells during pregnancy and postpartum in pts with AS
- Frequency was determined by flow cytometry in 10 pregnant and 5 nonpregnant pts and 14 pregnant and 4 nonpregnant healthy controls
- Pregnant individuals were investigated at third trimester and 8 wks postpartum
- Treg cells and CD4+CD25- effector T (Teff) cells were investigated for proliferation and cytokine secretion after stimulation with anti-CD3 and anti-CD28 monoclonal Abs
- Frequency of CD4+CD25high Treg cells was higher during pregnancy than postpartum in both healthy control and pts
- Treg cells in pregnant women with AS secreted only small amounts of IL-10 and showed lower suppression of TNF-α and interferon-γ secretion by CD4+CD25- Teff cells
- At postpartum time point, proinflammatory cytokine levels in the Treg/Teff cell cocultures and Teff cell monocultures were higher in pts
Related Articles
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09
Relevance Score: 69%
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research, 11/02/09
Relevance Score: 68%
Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism
Rheumatology International, 11/11/09
Relevance Score: 67%
Concomitant cervical and thoracic spinal fractures in ankylosing spondylitis: A case report and review of literature
Injury Extra, 11/05/09
Relevance Score: 67%
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Rheumatology, 12/20/09
The 'RASor's' edge: Ras proteins and matrix destruction in arthritis
Arthritis Research & Therapy, 12/19/09
Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation
Journal of Rheumatology, 12/17/09
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
Clinical Rheumatology, 12/17/09
Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population
Rheumatology International, 12/16/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


